TRANSCELERATE BIOPHARMA INC, of WEST CONSHOHOCKEN, PA, is a Public Charity tracked in Imperigo's IRS 990 database. The 2025 filing shows $34.2M in revenue, $33.0M in expenses, $55.1M in total assets.
THE ORGANIZATION'S MISSION IS TO COLLABORATE ACROSS THE GLOBAL BIOPHARMACEUTICAL R&D COMMUNITY TO IDENTIFY, DESIGN AND FACILITATE IMPLEMENTATION OF SOLUTIONS DESIGNED TO DRIVE THE EFFICIENT, EFFECTIVE AND HIGH QUALITY DELIVERY OF NEW MEDICINES.
How Transcelerate Biopharma Inc divides every $100 it spends, from its own Form 990 filings, averaged across 9 years.
No fundraising costs are reported. That often means fundraising runs through a separate affiliated organization that files its own return.
Source: Form 990 filings with the IRS, latest fiscal year 2025. Shares are from the organization's reported expenses. Data by Imperigo; not affiliated with the IRS.
Officer compensation and complete director data available with membership.
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2025 | $34.2M | $33.0M | $55.1M |
| 2024 | $38.6M | $31.7M | $55.3M |
| 2023 | $34.2M | $32.5M | $48.1M |
| 2022 | $33.6M | $34.3M | $48.5M |
| 2021 | $31.1M | $33.2M | $50.4M |
Between 2021 and 2025, reported annual revenue grew from $31.1M to $34.2M (+10%), with total assets most recently reported at $55.1M.
Interactive year-over-year charts and full filing details available with membership.
